Asthma and Allergy Foundation of America

Patient-Led Organizations Join Forces With Komodo Health To Drive Access to High-Quality Care Using Real-World Evidence

Retrieved on: 
Tuesday, February 14, 2023
Venture Capital, Clinical Trials, Professional Services, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Oncology, Komodo, Organization, The One Network, Australian Melanoma Research Foundation, Bone marrow, Multiple Myeloma Research Foundation, Chan Zuckerberg Initiative, Asthma and Allergy Foundation of America, Sarcoidosis, Diagnosis, FSR, Melanoma, Pancreatic serous cystadenoma, Patient, HIV disease progression rates, Entrepreneurship, Clinical trial, Pregnancy, Research, Black, Dermatology, Inflammation, Disease, Partnership, Education, Multiple myeloma, CRC, Asthma, Quality of life, Pharmaceutical industry, Nursing

These partnerships empower advocacy organizations to harness data-driven strategies to support patients and reduce disease burden at scale.

Key Points: 
  • These partnerships empower advocacy organizations to harness data-driven strategies to support patients and reduce disease burden at scale.
  • The Komodo Health platform and application suite are used by patient advocacy groups to put patient needs at the center of strategic decision-making by surfacing concrete, comprehensive insights into the care experiences of specific patient populations.
  • Komodo’s insights equip these organizations with real-world data to power their programs in ways that were previously out of reach.
  • “Patient advocacy groups play a critical, on-the-ground role in communities across the country to drive education and awareness, fund critical research, and improve standards of care for their patients,” said Web Sun, President and Co-Founder, Komodo Health.

TEZSPIRE® APPROVED FOR SELF-ADMINISTRATION IN THE U.S. WITH A NEW PRE-FILLED PEN

Retrieved on: 
Thursday, February 2, 2023
Caregiver, Vaccine, Helminthiasis, Tezepelumab, Ageing, Allergy, Rash, Asthma and Allergy Foundation of America, Medicine, Placentalia, Pharyngitis, Phenotype, Maintenance, Excipient, Patient, Incidence, Asthma, Back pain, Pregnancy, Fetus, Food, Severe cutaneous adverse reactions, Hypersensitivity, Allergic conjunctivitis, Amgen, Birth, FDA, Infection, AMGN, Miscarriage, AstraZeneca, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Anaphylaxis, European, Arthralgia, Acute exacerbation of chronic obstructive pulmonary disease, Pharmaceutical industry, Dietary supplement, EU

THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved TEZSPIRE® (tezepelumab-ekko) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.1 First approved by the FDA in December 2021, TEZSPIRE is the only biologic approved for severe asthma with no phenotype (e.g., eosinophilic or allergic) or biomarker limitation within its approved label.2-9

Key Points: 
  • "We believe self-administration alternatives can play an important role in patients' lives and address unmet needs for those living with severe asthma."
  • TEZSPIRE is currently approved for the treatment of severe asthma in the U.S., EU, Japan and other countries.
  • TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.
  • Hypersensitivity reactions were observed in the clinical trials (e.g., rash and allergic conjunctivitis) following the administration of TEZSPIRE.

AmeriHealth Caritas Offers Providers Training about the Dangers of Gas Stoves and Childhood Asthma

Retrieved on: 
Monday, January 16, 2023
Children, Other Health, Continuing, Training, Managed Care, Health, Consumer, General Health, Education, Disease, Climate change, Physicians for Social Responsibility, PSR, Physician, Pollutant, Social responsibility, Asthma, Stove, AAFA, Cooking, CEU, Risk, CME, Death, Patient, Prevalence, Asthma and Allergy Foundation of America, Inclusion, Nitrogen dioxide, Pharmaceutical industry, Medicine, Medicaid

AmeriHealth Caritas , a national leader in Medicaid managed care, is collaborating with a physician-led, national non-profit organization to provide training for its health care providers to learn how gas stoves contribute to childhood asthma and other respiratory ailments.

Key Points: 
  • AmeriHealth Caritas , a national leader in Medicaid managed care, is collaborating with a physician-led, national non-profit organization to provide training for its health care providers to learn how gas stoves contribute to childhood asthma and other respiratory ailments.
  • The webinar training program called Cooking with Gas: Health Harms from Gas Stoves will inform health care providers about the dangerous indoor air pollutants produced by natural gas appliances, what these pollutants do to the human body, and how they as health professionals can protect their patients and their families.
  • Upon completion of the course, health care providers will earn continuing medical education (CME) credits or continuing education unit (CEU) credits.
  • Cooking with gas stoves creates nitrogen dioxide, which has been linked with childhood asthma.

The Worldwide Allergic Conjunctivitis Industry is Estimated to Reach $2.9 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 4, 2023
Health, Optical, Conjunctivitis, Allergic conjunctivitis, Allergy, Conjunctiva, Allergen, Market share, Common, Allergic rhinitis, Eyelid, Urbanization, Porter's five forces analysis, Pollen, Itchy, Gonorrhea, National Centre for Cold-chain Development, Semen, Growth, Patient, Benchmarking, Vertically transmitted infection, Asthma, Distribution, Spore, Eye, STI, Asthma and Allergy Foundation of America, Prevalence, Chlamydia, Cosmetics, Marketing

The global allergic conjunctivitis market was valued at $1,937.99 million in 2021, and is estimated to reach $2,954.2 million by 2031, growing at a CAGR of 4.28% from 2022 to 2031.

Key Points: 
  • The global allergic conjunctivitis market was valued at $1,937.99 million in 2021, and is estimated to reach $2,954.2 million by 2031, growing at a CAGR of 4.28% from 2022 to 2031.
  • An allergic reaction to things such as pollen, mold, or spores can result in an eye inflammation known as allergic conjunctivitis.
  • The major factors that drive the growth of the allergic conjunctivitis market are increase in patient population suffering from ocular allergies.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergic conjunctivitis market analysis from 2021 to 2031 to identify the prevailing allergic conjunctivitis market opportunities.

Nasal Drug Delivery Market Report 2022-2028: Increasing Patients Pool of Asthma and COPD Drives Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 28, 2022
Health, Pharmaceutical, Government, Ageing, COPD, AAFA, Pocs, Concept, Depression, Brain, Nasal congestion, Gel, CDNF, Growth, 3M, Patient, AstraZeneca, BD (company), Chronic obstructive pulmonary disease, FDA, Hospital, Merck Group, Asthma and Allergy Foundation of America, Prevalence, Pharmaceutical industry, Marketing, Asthma

The global nasal drug delivery market is anticipated to grow at a substantial CAGR of 5.5% during the forecast period.

Key Points: 
  • The global nasal drug delivery market is anticipated to grow at a substantial CAGR of 5.5% during the forecast period.
  • The rising prevalence of Asthma and chronic obstructive pulmonary disease (COPD) are factors that are driving the market growth.
  • Increasing patients pool of asthma and COPD across the globe are factors that increase the demand for nasal drugs for the treatment of diseases in the market.
  • The nasal drug delivery is segmented on the basis of dosage form, containers, therapeutic application, and end-user.

'No Equal in the Industry': Tarkett's Powerbond® RS is World's First CERTIFIED asthma & allergy friendly® Soft Surface Flooring

Retrieved on: 
Friday, December 9, 2022
Asthma, Material, Certification, Cradle-to-cradle design, Housing, Atmosphere, Volatile organic compound, Life, Dust, School, Carbon footprint, Chromosome 8, Wood, Science, Hospital, Allergen, ASL, Restart, Asthma and Allergy Foundation of America, Health, Allergy, AAFA, History, Rubber industry in Malaysia, Multimedia, Organic compound, Carbon, Dairy product, Risk management, Pharmaceutical industry

Powerbond RS was specifically developed to address potential problems associated with indoor air quality and building-related illness.

Key Points: 
  • Powerbond RS was specifically developed to address potential problems associated with indoor air quality and building-related illness.
  • Powerbond RS is a hybrid resilient flooring, meaning it combines the look and feel of carpet with the durability and cleanability of a resilient surface.
  • Made with an impermeable, closed-cell cushion backing and installed with chemically welded seams, Powerbond RS provides a wall-to-wall moisture barrier to prevent mold and mildew.
  • To become CERTIFIED asthma & allergy friendly, a product must pass rigorous, product-specific standards developed by ASL's team of scientistsand reviewed by AAFA's medical experts.

WELCOME THE HOLIDAY SEASON WITH TOP DEALS ON LG HOME APPLIANCES

Retrieved on: 
Wednesday, November 16, 2022
FDIC, Technology, Asthma, Tax, Refrigeration, AirCare, Electronics, Washer, Vacuum, Program, Allergy, Visa, Cooking, LG Corporation, Black Friday, LG Electronics, MSRP, Chase Bank, Wi-Fi, Quanta Computer, Inc. v. LG Electronics, Inc., Steam, Pacific Time Zone, Allergen, Asthma and Allergy Foundation of America, LG, JPMorgan Chase, Washer-dryer, Home appliance, Consumer electronics, Health insurance, Kompressor

ENGLEWOOD CLIFFS, N.J., Nov. 16, 2022 /PRNewswire/ -- LG's Black Friday promotions are back with huge savings on top-rated home appliances just in time to ring in the holiday season. LG Electronics USA is offering incredible deals on appliance packages from the kitchen to the laundry room.

Key Points: 
  • LG Electronics USA is offering incredible deals on appliance packages from the kitchen to the laundry room.
  • Consumers now have the chance to save big this holiday season and upgrade their homes with the latest innovative appliances from LG.
  • LG InstaView refrigerators with Craft Ice are the perfect solution for entertaining in style, with spherical ice that elevates any drink.
  • LG ElectronicsUSA, Inc., based inEnglewood Cliffs, N.J., is the North American subsidiary of LG Electronics, Inc., a$63 billionglobal innovator in technology and manufacturing.

AAFA Applauds EPA’s $1 Billion Investment in Clean School Buses to Benefit Millions of Children With Asthma

Retrieved on: 
Wednesday, October 26, 2022
Atopic dermatitis, Food, National Health Council, Asthma, Investment, Disease, Transport, Allergy, Lincoln Hospital (Bronx), Color, CEO, Dermatitis, Death, Patient, Climate change, EPA, AAFA, BIL, Education, Research, GLOBE, Environmental protection, Environmental policy of the Joe Biden administration, Asthma and Allergy Foundation of America, Air pollution, Atmosphere, Health, Public health, Pharmaceutical industry

Asthma is the most common chronic condition in children and one of the leading causes of hospitalizations and school absenteeism.

Key Points: 
  • Asthma is the most common chronic condition in children and one of the leading causes of hospitalizations and school absenteeism.
  • Yet, children are exposed to dirty, diesel-powered school buses daily on their way to and from school and are unfairly suffering the health and academic consequences.
  • AAFA applauds the programs prioritization of low-income, rural, and tribal communities as neither air pollution nor asthma impact all communities equally.
  • AAFA will continue to support the transition to zero-emission school buses to ensure all children have safe air to breathe and environments to learn.

LG IS UPGRADING LAUNDRY DAY WITH ALL-NEW SMART FRONT LOAD & TOP LOAD WASHERS AND DRYERS

Retrieved on: 
Monday, October 17, 2022
Steam, LG Electronics, Technology, LG ThinQ, Convenience, Asthma and Allergy Foundation of America, Borland Sidekick, Quanta Computer, Inc. v. LG Electronics, Inc., Mutual fund, Black Steel, LG, Allergen, Asthma, Electronics, LG Corporation, AI, Clothing, Water, Female gendering of AI technologies, Agitators, Wi-Fi, Turbosteamer, Ultimate, Consumer electronics, Dry cleaning

ENGLEWOOD CLIFFS, N.J., Oct. 17, 2022 /PRNewswire/ -- LG Electronics USA (LG) is reimagining laundry day with the introduction of its newly-designed Smart Front Load Washer and Dryer Pair. Featuring a sleek esthetic and dovetailed with cutting-edge built-in intelligence, the latest models deliver the utmost in cleaning performance and convenience. LG is also releasing new top load washer and dryer models to offer consumers an array of options to suit their laundry needs. These latest laundry solutions feature LG's exclusive TurboWash® 360° and TurboSteam™ technology along with a variety of tech-forward features to make laundry routines effortless.

Key Points: 
  • LG is also releasing new top load washer and dryer models to offer consumers an array of options to suit their laundry needs.
  • These latest laundry solutions feature LG's exclusive TurboWash 360 and TurboSteam technology along with a variety of tech-forward features to make laundry routines effortless.
  • Along with many of LG's top-rated washers and dryers, both of the new Front Load and Top Load laundry models are CERTIFIEDasthma & allergy friendlyby the Asthma and Allergy Foundation of America.
  • LG's new Smart Front Load Washer and Dryer Pair is now available at LG.com and retailers nationwide starting at $1,599, and the Top Load Washers are available starting at$949.

New 'Voice of the Patient' Report Highlights Unmet Needs of Asthma in Childhood

Retrieved on: 
Tuesday, September 20, 2022
Human voice, Health, Food, German American Partnership Program, Charity Navigator, Asthma and Allergy Foundation of America, American Lung Association, Obesity, Industry, Atopic dermatitis, Lung cancer, Patient, Regulation of tobacco by the U.S. Food and Drug Administration, Dermatitis, Exercise, Quality of life, Bone loss, Candid (organization), Allergy, Degenerative disease, Diagnosis, Drug development, Caregiver, Patient-Reported Outcomes Measurement Information System, Sleep, Research, GLOBE, Awareness, Education, Disease, AAFA, Pharmaceutical industry, Asthma

The Voice of the Patient Report on Asthma in Childhood summarizes findings from the Little Airways, Big Voices initiative and identifies what is important to people who live with and manage asthma in childhood.

Key Points: 
  • The Voice of the Patient Report on Asthma in Childhood summarizes findings from the Little Airways, Big Voices initiative and identifies what is important to people who live with and manage asthma in childhood.
  • The Voice of the Patient report explores current and future approaches to treating childhood asthma.
  • We published the Voice of the Patient Report on Asthma in Childhood to inform the development and regulatory review of potential new asthma treatments that are meaningful to children with asthma.
  • There are still unmet needs in prevention, diagnosis, treatment, and progression of asthma in childhood.